Atlas Trials

A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia

Clinical trial NCT03381287 · COMPLETED

Trial details

NCT number
NCT03381287
Sponsor
HighTide Therapeutics (Hong Kong) Limited
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hypercholesterolemia
Start date
2018-04-13
Primary completion
2018-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.